Save the Date – June 13th – 14th This year we will host our Continuous Flow Processing Conference in Dunboyne Castle, Co Meath, 20 mins from Dublin Airport, Ireland. Details of the agenda will be released shortly…click the link below to register. Click here: Registration Link
An open letter from our CEO, Joerg Ahlgrimm to SK pharmteco Customers SK pharmteco’s mission is to improve patient outcomes and save lives by partnering with our customers to produce and deliver life changing therapies through manufacturing and technical excellence, a positive and adaptable workforce, and an intense focus on safety, quality, and innovation. Our …
An open letter from our CEO, Joerg Ahlgrimm, to SK pharmteco Customers Read More »
RANCHO CORDOVA, CA – January 9, 2023 – SK pharmteco, a global contract development and manufacturing organization serving the pharmaceutical industry, today announced that David Lowndes will be appointed as Chief Operating Officer. David will lead the company’s global Supply Chain, Quality, Regulatory Affairs, R&D, IT/Digital, and Operational Excellence functions through a period of significant …
SK pharmteco Appoints David Lowndes as Chief Operating Officer Read More »
We’re in the news… check out the latest issue of #chemicalsknowledgehub featuring an article focused on our innovative skids for small scale #continuousflowprocessing developed by teams at our #RanchoCordova site, led by Dr William DuBay VP R&D #SKpharmteco, and AMPAC Fine Chemicals’ Dr John Jacobsen Executive Director R&D and Dr Ryan Woods Senior Manager R&D …
SK pharmteco (SKPT) a global CDMO, part of SK Inc., is pleased to announce that it has launched SK biotek Ireland Analytical Services offering full cGMP testing services including testing of Highly Potent Active Pharmaceutical Ingredients (i.e. material with Occupational Exposure Levels (OEL) < 0.1 µg/m³) from SK biotek Ireland’s Dublin-based pharmaceutical manufacturing plant. The …
We’re in the news… click the link to read the full article https://lnkd.in/evaqHhDW
We’re in the news…click the link to read the full article https://biomag1.com/sk-pharmteco-appoints-joerg-ahlgrimm-as-ceo/
Exclusive: SK Pharmteco’s French CDMO to complete construction of new plant in Q1 2023 Yposkesi CEO Alain Lamproye says 2nd plant expected to begin operation at start of 2024. FRANKFURT, Germany — Yposkesi, SK Pharmteco’s French contract development and manufacturing organization specialized in cell and gene therapy, is expecting to complete the construction of its …
SK pharmteco appoints Joerg Ahlgrimm as CEO November 1, 2022 – SK pharmteco, a global contract development and manufacturing organization (CDMO) serving the pharmaceutical industry, today announced that Joerg Ahlgrimm will be appointed as the Chief Executive Officer. Ahlgrimm will assume the global leadership of the company and spearhead its next phase of innovation and …
We’re in the news…Business Korea ‘SK Inc. Expanding into CGT CDMO Business’ click the link to read the full article https://lnkd.in/ecpPw8Z9
"*" indicates required fields
